Bioio, Inc.

St. Louis, MO

UEI
NCX4S2YKK6A8
CAGE
7ZZJ2
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Sole Proprietorship
SAM.gov registration date
Physical address
4340 Duncan Ave #236, St. Louis, MO 63110, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Drug target identification using crispri/a screening R41GM137625 National Institute of General Medical Sciences (NIH) $224,455
Novel insulin-sensitizing nash/diabetes drugs. R42DK121652 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $3,208,973

Quick answers

Is Bioio, Inc. registered in SAM.gov?

Yes. Bioio, Inc.'s SAM.gov registration is active through May 18, 2027.

What is Bioio, Inc.'s most recent federal award?

Bioio, Inc.'s most recent federal grant award is Drug target identification using crispri/a screening (R41GM137625), from National Institute of General Medical Sciences (NIH), on May 1, 2020.

On GovTribe

See Bioio, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login